Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

BETAMETHASONE SODIUM PHOSPHATE

BETAMETHASONE SODIUM PHOSPHATE

Standard Dose
EQ 3MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BETAMETHASONE SODIUM PHOSPHATE is listed in Drugs@FDA under application 085738 (ANDA).

Marketing status: Discontinued Active ingredient BETAMETHASONE SODIUM PHOSPHATE Form and strength INJECTABLE;INJECTION - EQ 3MG BASE/ML Sponsor WATSON LABS Submission history Latest submission status date: 1999-02-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview BETAMETHASONE SODIUM PHOSPHATE is listed in Drugs@FDA under application 085738 (ANDA). Marketing status: Discontinued Active ingredient BETAMETHASONE SODIUM PHOSPHATE Form and strength INJECTABLE;INJECTION - EQ 3MG BASE/ML Sponsor WATSON LABS Submission history Latest submission status date: 1999-02-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.